Pure Red Cell Aplasia Associated With Administration of Sustained-Release Procainamide

doi:10.1001/archinte.1987.00370060175029

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Vol. 147 No. 6, June 1987

Online Only
	•	Online First Table of Contents

CLINICAL OBSERVATIONS

•	Online Features

This Article
•	References
•	Full text PDF
•	Reply to article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Citation map
•	Citing articles on Web of Science (8)
•	Contact me when this article is cited

Related Content
•	Similar articles in this journal

Social Bookmarking
	What's this?

Pure Red Cell Aplasia Associated With Administration of Sustained-Release Procainamide

Leonard Giannone, MD; John W. Kugler, MD; Sanford B. Krantz, MD

Arch Intern Med. 1987;147(6):1179-1180.

Abstract

• Pure red cell aplasia developed in a patient with small-celllung cancer who was also taking sustained-release procainamide.Shortly after discontinuation of the procainamide preparation,a reticulocytosis and increasing hemoglobin level were observed.

(Arch Intern Med 1987;147:1179-1180)

Author Affiliations

From the Division of Hematology, Department of Medicine, Veterans Administration Medical Center and Vanderbilt University, Nashville, Tenn (Drs Giannone and Krantz); and Oncology/Hematology Associates of Central Illinois, Bloomington (Dr Kugler).

Footnotes

Accepted for publication Nov 24, 1986.

Reprint requests to Veterans Administration Medical Center,Room B201, 1310 24th Ave S, Nashville, TN 37202 (Dr Giannone).

Add to CiteULike CiteULike Add to Connotea Connotea Add to Delicious Delicious Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

| | |